Skip to main content

Menopause clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens

    Sorry, not currently recruiting here

    Women at risk for development of breast cancer and experiencing vasomotor menopausal symptoms (hot flashes) will be randomized to bazedoxifene (BZA) plus conjugated estrogens (CE) for 6 months versus a wait list control. Two risk factors for development of breast cancer will be studied pre-study and after 6 months: fibroglandular volume (FGV) on mammogram as assessed by Volpara software and proliferation by Ki-67 immunocytochemistry in benign breast tissue acquired by random periareolar fine needle aspiration (RPFNA). Change in biomarkers will be compared between groups.

    San Francisco, California and other locations

Our lead scientists for Menopause research studies include .